Scientific Reports · 2020 · 28 citations · 60 references
MedicineOncologyRadiation OncologyCancer PharmacologyDna RepairMolecular OncologyRadiation TherapyRadiobiological ConsiderationsCancer Cell RadiosensitivityClonogenic Survival AssaysPi3k InhibitorsPi3k SignalingPi3k-akt Signaling PathwayPi3k-akt-mtor SignalingTargeted Kinase InhibitionTherapeutic Radiosensitization
Radiotherapy has a central role in the treatment of head and neck squamous cell carcinoma (HNSCC). Activation of the PI3K/AKT/mTOR pathway can decrease the efficiency of radiotherapy via the promotion of cell survival and DNA repair. Here, the influence of PI3K pathway inhibition on radiotherapy response was investigated. Two PI3K inhibitors were investigated and both BKM120 and GDC0980 effectively inhibited cellular and clonogenic growth in 6 HNSCC cells, both HPV-positive as well as HPV-negative. Despite targeted inhibition of the pathway and slight increase in DNA damage, PI3K inhibition did not show significant radiosensitization. Currently only one clinical trial is assessing the effectiveness of combining BKM120 with RT in HNSCC (NCT02113878) of which the results are eagerly awaited.
60
Comprehensive genomic characterization of head and neck squamous cell carcinomas
COSMIC: somatic cancer genetics at high-resolution
Simon Forbes, David Beare, Harry Boutselakis et al. · Nucleic Acids Research · 2016 · 2.1K citations · Full text
M. Hashibe, Paul E. Brennan, Simone Benhamou et al. · JNCI Journal of the National Cancer Institute · 2007 · 1.1K citations · Full text
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
Vivian Wai Yan Lui, Matthew L. Hedberg, Hua Li et al. · Cancer Discovery · 2013 · 584 citations · Full text